DNA Methylation Market Report 2022: Increasing Adoption of DNA Methylation Technology in Oncology Research Bolsters Growth – ResearchAndMarkets.com

DUBLIN–(WORKING WIRE)–The “DNA Methylation Market Size, Share & Trends Analysis Report By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region, and Segment Forecasts, 2022 – The 2030 report” has been added to ResearchAndMarkets.com’s give.

The global DNA methylation market size is estimated to reach $4.22 billion by 2030. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increased use of methylation. DNA analysis. The expansion of DNA methylation in the field of agrigenomics continues to be a promising development.

In January 2020, a research paper published in Springer showed that DNA methylation and expression analysis show that diseases resistant to peanut foliar disease are epialleles. The analysis of DNA methylation continues to open new doors of opportunities for researchers and pharmaceutical companies. Increased research and development in this field will further strengthen the DNA methylation industry in the coming years.

In addition, the growth of esophageal adenocarcinoma contributed to the overall growth. According to data published by the American Cancer Society (ACS), in the year 2022, it is estimated that there will be 20,640 undiagnosed esophageal cancer cases in the U.S. Cancer will cause 16,410 deaths.

The growing number of esophageal cancer cases in the US highlights the urgent need for early intervention that can help improve poor survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers can be used to detect esophageal adenocarcinoma and high-grade dysplasia.

The increasing adoption of epigenetics-based treatment strategies, coupled with the large number of nucleic acid-based diagnostic tests & kits commercialization is expected to drive the growth of the market. In May 2022, an article published in PubMed stated that therapeutic strategies based on epigenetics will be used to study Alzheimer’s disease. However, the lack of knowledge to perform DNA methylation tests can limit growth. DNA methylation has significant potential in various biotechnology applications, although the low number of skilled technicians continues to hinder growth.

DNA Methylation Market Reports

  • The overall development is linked to the development of DNA methylation in the analysis of molecular biology and genomics and agrigenomics fields.

  • Technologically, the sequencing segment will have the highest share in 2021, due to the expansion of sequencing technology for research purposes by market players.

  • By product, the consumables segment is the most used in the market as it is widely used in DNA and disease processes.

  • In terms of demand, the medical research segment has dominated the market due to the increase in clinical trials for various diseases worldwide, and continued government support leading to an increase in R&D expenses.

  • In end-use, pharmaceutical and biotechnology companies dominate the market, thanks to the increasing use of high-throughput technologies such as NGS by key market players.

  • North America dominates the market in 2021 due to the extensive industry of manufacturing and R&D equipment. A growing number of product launches, FDA approvals, and the presence of key market players continue to promise growth in this area.

Marketing Efforts

Market Drivers

  • Expanding Use of DNA Methylation Technology in Oncology Research

  • Cancer is on the rise worldwide

  • Expanding Use of DNA Methylation as Epigenetic Biomarkers

Market Restrictions

  • Lack of knowledge and Biotechnological knowledge to perform DNA Methylation tests

  • Limited Use of DNA Methylation as a Clinical Test

Main topics covered:

Chapter 1 DNA Methylation Market: Methodology and Scope

Chapter 2 DNA Methylation Market: Summary

Chapter 3 DNA Methylation Market: Business Analysis

Chapter 4 DNA Methylation Market: Competitive Landscape

Chapter 5 DNA Methylation Market: Technical Business Analysis

5.1 DNA Methylation Market: Technical Analysis

5.2 Polymerase chain reaction (PCR)

5.3 Microarrays

5.4 Arrangement

5.5 Miscellaneous

Chapter 6 DNA Methylation Market: Product Industry

6.1 DNA Methylation Market: Product Overview

6.2 Termination

6.3 Kicks and Adjustments

6.4 Enzymes

6.5 Hardware and Software

Chapter 7 DNA Methylation Market: Business Analysis

7.1 DNA Methylation Market: Trends Analysis

7.2 Gene therapy

7.3 Research

7.4 Information

7.5 Miscellaneous

Chapter 8 DNA Methylation Market: Industry End Use

8.1 DNA Methylation Market: End-Use Trends

8.2 Hospitalization & Disclosure

8.3 Pharmaceutical & Biotechnology Companies

8.4 Research and Science

Chapter 9 DNA Methylation Market: Regional Business Analysis

Chapter 10 DNA Methylation Market: Business Introduction

The said Companies

  • New England Biolabs

  • Sysmex Corporation

  • Abcam plc.

  • F. Hoffmann-La Roche Ltd.

  • Diagenode Diagnostics SA

  • Thermo-Fisher Scientific Inc.

  • Agilent Technologies Inc.

  • Biorad Laboratories Inc.

  • Exact Science Department

  • Qiagen NV

  • Active Motif, Inc.

  • Illumina Inc.

  • Epigentek Group Inc.

  • Pacific Biosciences Inc.

  • New England Biolabs Inc.

  • Merck Inc

  • Zymo Research Corporation

  • Perkinelmer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ys2809.

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for global market research reports and market data. We provide you with the latest data on global markets and sectors, important companies, top companies, new products and new trends.


Also Read :  Why the Math Around Adaptive AI is Painful

Leave a Reply

Your email address will not be published.

Related Articles

Back to top button